Carlos Armiñanzas

1.6k total citations
20 papers, 170 citations indexed

About

Carlos Armiñanzas is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Carlos Armiñanzas has authored 20 papers receiving a total of 170 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Infectious Diseases and 9 papers in Surgery. Recurrent topics in Carlos Armiñanzas's work include Congenital Anomalies and Fetal Surgery (4 papers), Parasitic infections in humans and animals (4 papers) and Infective Endocarditis Diagnosis and Management (4 papers). Carlos Armiñanzas is often cited by papers focused on Congenital Anomalies and Fetal Surgery (4 papers), Parasitic infections in humans and animals (4 papers) and Infective Endocarditis Diagnosis and Management (4 papers). Carlos Armiñanzas collaborates with scholars based in Spain. Carlos Armiñanzas's co-authors include María Carmen Fariñas, Manuel Gutiérrez‐Cuadra, José Barberán, Marta Fernández-Sampedro, Patricia Muñóz, Francisco Arnaíz de las Revillas, Jordi Carratalà, Carlos Cervera, Francisco López‐Medrano and Asunción Moreno and has published in prestigious journals such as Scientific Reports, International Journal of Infectious Diseases and Journal of Clinical Medicine.

In The Last Decade

Carlos Armiñanzas

20 papers receiving 165 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos Armiñanzas Spain 9 78 57 53 33 24 20 170
Jean‐Baptiste Giot Belgium 7 115 1.5× 34 0.6× 52 1.0× 27 0.8× 10 0.4× 17 210
Dariusz Wasiak Poland 12 140 1.8× 198 3.5× 49 0.9× 20 0.6× 13 0.5× 29 387
Dominique Merrien France 9 61 0.8× 40 0.7× 66 1.2× 7 0.2× 37 1.5× 18 238
Martín Tagle Peru 9 63 0.8× 160 2.8× 12 0.2× 19 0.6× 6 0.3× 36 390
Pierre‐Marie Roger France 10 102 1.3× 22 0.4× 66 1.2× 4 0.1× 18 0.8× 24 198
Ashrit Multani United States 10 91 1.2× 34 0.6× 82 1.5× 5 0.2× 7 0.3× 25 205
Biana Dubinsky‐Pertzov Israel 9 65 0.8× 81 1.4× 60 1.1× 7 0.2× 9 0.4× 31 319
Handan Alay Türkiye 8 54 0.7× 27 0.5× 75 1.4× 4 0.1× 4 0.2× 48 197
Bahadır Ceylan Türkiye 10 144 1.8× 33 0.6× 44 0.8× 4 0.1× 19 0.8× 26 249
E Cañas Spain 9 93 1.2× 59 1.0× 39 0.7× 7 0.2× 3 0.1× 19 195

Countries citing papers authored by Carlos Armiñanzas

Since Specialization
Citations

This map shows the geographic impact of Carlos Armiñanzas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Armiñanzas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Armiñanzas more than expected).

Fields of papers citing papers by Carlos Armiñanzas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Armiñanzas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Armiñanzas. The network helps show where Carlos Armiñanzas may publish in the future.

Co-authorship network of co-authors of Carlos Armiñanzas

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Armiñanzas. A scholar is included among the top collaborators of Carlos Armiñanzas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Armiñanzas. Carlos Armiñanzas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrer‐Pargada, Diego, Carlos Antonio Amado Diago, Beatriz Abascal-Bolado, et al.. (2025). FeNO as a biomarker of interstitial and fibrotic pulmonary sequelae in patients admitted for severe SARS-CoV-2 pneumonia. Scientific Reports. 15(1). 25696–25696. 1 indexed citations
2.
Rodríguez, Pérez, Adrián Sousa, Josune Goikoetxea, et al.. (2024). Mortality impact of further delays in active targeted antibiotic therapy in bacteraemic patients that did not receive initial active empiric treatment: Results from the prospective, multicentre cohort PROBAC. International Journal of Infectious Diseases. 145. 107072–107072. 1 indexed citations
3.
Martínez‐Sellés, Manuel, Patricia Muñóz, Carlos Armiñanzas, et al.. (2024). Infective endocarditis in HIV-infected patients. Analysis of a national cohort. Infectious Diseases. 56(12). 1057–1066. 1 indexed citations
4.
Pérez-Rivera, Jose-Ángel, Carlos Armiñanzas, Patricia Muñóz, et al.. (2022). Comorbidity and Prognosis in Octogenarians with Infective Endocarditis. Journal of Clinical Medicine. 11(13). 3774–3774. 6 indexed citations
5.
Blanco, José Ramón, Carlos Armiñanzas, Enrique Bernal, et al.. (2022). Elevated levels of serum CDCP1 in individuals recovering from severe COVID-19 disease. Aging. 14(4). 1597–1610. 3 indexed citations
6.
Armiñanzas, Carlos, Francisco Arnaíz de las Revillas, Manuel Cuadra, et al.. (2021). Usefulness of the COVID-GRAM and CURB-65 scores for predicting severity in patients with COVID-19. International Journal of Infectious Diseases. 108. 282–288. 11 indexed citations
7.
Revillas, Francisco Arnaíz de las, Vicente González‐Quintanilla, José Hernán Parra Sánchez, et al.. (2021). Evaluation of endothelial function and subclinical atherosclerosis in patients with HIV infection. Scientific Reports. 11(1). 18431–18431. 8 indexed citations
8.
Revillas, Francisco Arnaíz de las, et al.. (2018). Daptomycin treatment in Gram-positive vascular graft infections. International Journal of Infectious Diseases. 68. 69–73. 8 indexed citations
9.
Armiñanzas, Carlos, et al.. (2016). Papel de la bacteriobilia en las complicaciones postoperatorias. Revista española de quimioterapia. Suplemento. 29(3). 123–129. 1 indexed citations
10.
Armiñanzas, Carlos, et al.. (2016). [Bacteriobilia: a non-resolved problem].. PubMed. 29(3). 113–8. 3 indexed citations
11.
Armiñanzas, Carlos, et al.. (2016). [Role of bacteriobilia in postoperative complications].. PubMed. 29(3). 123–9. 6 indexed citations
12.
Armiñanzas, Carlos, et al.. (2015). Hidatidosis: aspectos epidemiológicos, clínicos, diagnósticos y terapéuticos. Revista española de quimioterapia. Suplemento. 28(3). 116–124. 15 indexed citations
13.
Armiñanzas, Carlos, Manuel Gutiérrez‐Cuadra, & María Carmen Fariñas. (2015). [Hydatidosis: epidemiological, clinical, diagnostic and therapeutic aspects].. PubMed. 28(3). 116–24. 12 indexed citations
14.
15.
16.
Diago, Carlos Antonio Amado, et al.. (2015). Echinococcosis: A 15-year epidemiological, clinical and outcome overview. Revista Clínica Española. 215(7). 380–384. 9 indexed citations
17.
Pajarón, Marcos, Ana Arnáiz, Manuel Gutiérrez‐Cuadra, et al.. (2015). Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: A safe and effective model. European Journal of Internal Medicine. 26(2). 131–136. 23 indexed citations
18.
Diago, Carlos Antonio Amado, et al.. (2015). Echinococcosis: A 15-year epidemiological, clinical and outcome overview. Revista Clínica Española (English Edition). 215(7). 380–384. 1 indexed citations
19.
Armiñanzas, Carlos, et al.. (2013). CURB-65 as an initial prognostic score in Internal Medicine patients. European Journal of Internal Medicine. 24(5). 416–419. 9 indexed citations
20.
Fariñas, María Carmen, Marta Fernández-Sampedro, & Carlos Armiñanzas. (2012). Formas clínicas y tratamiento de las infecciones causadas por otros hongos filamentosos. Enfermedades Infecciosas y Microbiología Clínica. 30(7). 414–419. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Baptiste Giot Breakdown of academic impact, for papers by Dariusz Wasiak Breakdown of academic impact, for papers by Dominique Merrien Breakdown of academic impact, for papers by Martín Tagle Breakdown of academic impact, for papers by Pierre‐Marie Roger Breakdown of academic impact, for papers by Ashrit Multani Breakdown of academic impact, for papers by Biana Dubinsky‐Pertzov Breakdown of academic impact, for papers by Handan Alay Breakdown of academic impact, for papers by Bahadır Ceylan Breakdown of academic impact, for papers by E Cañas
Rankless by CCL
2026